Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.
DeepMind Expects Clinical Trials for AI-Designed Drugs This Year
This was originally published on post